Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 9(8): e104429, 2014.
Article in English | MEDLINE | ID: mdl-25101672

ABSTRACT

Although many terpenes have shown antitumor, antibacterial, antifungal, and antiparasitic activity, the mechanism of action is not well established. Electron paramagnetic resonance (EPR) spectroscopy of the spin-labeled 5-doxyl stearic acid revealed remarkable fluidity increases in the plasma membrane of terpene-treated Leishmania amazonensis promastigotes. For an antiproliferative activity assay using 5×10(6) parasites/mL, the sesquiterpene nerolidol and the monoterpenes (+)-limonene, α-terpineol and 1,8-cineole inhibited the growth of the parasites with IC50 values of 0.008, 0.549, 0.678 and 4.697 mM, respectively. The IC50 values of these terpenes increased as the parasite concentration used in the cytotoxicity assay increased, and this behavior was examined using a theoretical treatment of the experimental data. Cytotoxicity tests with the same parasite concentration as in the EPR experiments revealed a correlation between the IC50 values of the terpenes and the concentrations at which they altered the membrane fluidity. In addition, the terpenes induced small amounts of cell lysis (4-9%) at their respective IC50 values. For assays with high cell concentrations (2×10(9) parasites/mL), the incorporation of terpene into the cell membrane was very fast, and the IC50 values observed for 24 h and 5 min-incubation periods were not significantly different. Taken together, these results suggest that terpene cytotoxicity is associated with the attack on the plasma membrane of the parasite. The in vitro cytotoxicity of nerolidol was similar to that of miltefosine, and nerolidol has high hydrophobicity; thus, nerolidol might be used in drug delivery systems, such as lipid nanoparticles to treat leishmaniasis.


Subject(s)
Cell Membrane/metabolism , Cyclohexenes/pharmacology , Drug Delivery Systems , Leishmania/metabolism , Membrane Lipids/metabolism , Sesquiterpenes/pharmacology , Terpenes/pharmacology , Electron Spin Resonance Spectroscopy , Leishmaniasis/diet therapy , Leishmaniasis/metabolism , Limonene
2.
Antimicrob Agents Chemother ; 58(6): 3021-8, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24614380

ABSTRACT

Miltefosine (MT) is a membrane-active alkylphospholipid licensed for the topical treatment of breast cancer skin metastases and the oral treatment of leishmaniasis, although its mechanism of action remains unclear. Electron paramagnetic resonance (EPR) spectroscopy of a spin-labeled lipid and a thiol-specific spin label in the plasma membrane of Leishmania promastigotes showed that MT causes dramatic increases in membrane dynamics. Although these alterations can be detected using a spin-labeled lipid, our experimental results indicated that MT interacts predominantly with the protein component of the membrane. Cell lysis was also detected by analyzing the supernatants of centrifuged samples for the presence of spin-labeled membrane fragments and cytoplasmic proteins. Using a method for the rapid incorporation of MT into the membrane, these effects were measured immediately after treatment under the same range of MT concentrations that cause cell growth inhibition. Cytotoxicity, estimated via microscopic counting of living and dead cells, indicated ∼70% cell death at the concentration of MT at which EPR spectroscopy detected a significant change in membrane dynamics. After this initial impact on the number of viable parasites, the processes of cell death and growth continued during the first 4 h of incubation. The EPR spectra of spin-labeled membrane-bound proteins were consistent with more expanded and solvent-exposed protein conformations, suggesting a detergent-like action. Thus, MT may form micelle-like structures around polypeptide chains, and proteins with a higher hydrophobicity may induce the penetration of hydrophilic groups of MT into the membrane, causing its rupture.


Subject(s)
Antineoplastic Agents/pharmacology , Leishmania mexicana/drug effects , Membrane Lipids/metabolism , Membrane Proteins/metabolism , Phosphorylcholine/analogs & derivatives , Cell Membrane/metabolism , Cell Survival/drug effects , Electron Spin Resonance Spectroscopy , Humans , Hydrophobic and Hydrophilic Interactions , Leishmania mexicana/metabolism , Micelles , Molecular Dynamics Simulation , Phosphorylcholine/chemistry , Phosphorylcholine/pharmacology , Protein Conformation , Spin Labels
3.
J Pharm Sci ; 102(5): 1661-9, 2013 May.
Article in English | MEDLINE | ID: mdl-23457073

ABSTRACT

Miltefosine (MT) is an alkylphospholipid that has been approved for the treatment of breast cancer metastasis and visceral leishmaniasis, although its mechanism of action remains poorly understood. Electron paramagnetic resonance spectroscopy of a spin-labeled lipid and a thiol-specific spin label showed that MT causes an increase in the molecular dynamics of erythrocyte ghost membranes and detergent-resistant membranes (DRMs) prepared from erythrocyte ghosts. In the vesicles of lipid raft constituents, it was shown that 20 mol % sphingomyelin could be replaced by 20 mol % MT with no change in the molecular dynamics. The effect of MT in DRMs was more pronounced than in erythrocyte ghosts, supporting the hypothesis that MT is a lipid raft modulator. At the reported MT-plasma concentrations found during the treatment of leishmaniasis (31-90 µg/mL), our measurements in the blood plasma indicated a hemolytic level of 2%-5%. The experiments indicated that MT acts predominantly on the protein component of the membrane. MT aggregates may wrap around the hydrophobic polypeptide chains, forming micelle-like structures that stabilize protein conformations more exposed to the solvent. Proteins with higher hydrophobicity may induce the penetration of the hydrophilic groups of MT into the membrane and cause it to rupture.


Subject(s)
Antineoplastic Agents/metabolism , Antiprotozoal Agents/metabolism , Erythrocyte Membrane/drug effects , Membrane Lipids/metabolism , Membrane Proteins/metabolism , Phosphorylcholine/analogs & derivatives , Antineoplastic Agents/blood , Antiprotozoal Agents/blood , Erythrocyte Membrane/metabolism , Hemolysis/drug effects , Humans , Membrane Microdomains/drug effects , Membrane Microdomains/metabolism , Phosphorylcholine/blood , Phosphorylcholine/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...